- Filed
- Feb 9, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Feb 4, 2026 | 24.92M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 25.19M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 25.17M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2024 | 25.14M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2024 | 25.12M sh |
| Dividends Paid | Q3 2026 · Dec 31, 2025 | $60.86M |
| Dividends Paid | Q3 2026 · Dec 31, 2024 | $59.67M |
| Capex | Q3 2026 · Dec 31, 2025 | $40.3M |
| Capex | Q3 2026 · Dec 31, 2024 | $54.89M |
| Operating Cash Flow | Q3 2026 · Dec 31, 2025 | −$58.04M |
| Operating Cash Flow | Q3 2026 · Dec 31, 2024 | $168.23M |
| Long Term Debt | Q3 2026 · Dec 31, 2025 | $616.59M |
| Long Term Debt | Q3 2026 · Mar 31, 2025 | $617.92M |
| Long Term Debt | Q3 2026 · Dec 31, 2024 | $617.78M |
| Short Term Debt | Q3 2026 · Dec 31, 2025 | $462.25M |
| Short Term Debt | Q3 2026 · Mar 31, 2025 | $455.04M |
| Short Term Debt | Q3 2026 · Dec 31, 2024 | $538.53M |
| Cash And Equivalents | Q3 2026 · Dec 31, 2025 | $85.23M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2025 | $260.12M |
| Cash And Equivalents | Q3 2026 · Dec 31, 2024 | $215.11M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $1.48B |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $1.46B |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | $1.45B |
| Current Liabilities | Q3 2026 · Dec 31, 2025 | $751.45M |
| Current Liabilities | Q3 2026 · Mar 31, 2025 | $750.16M |
| Current Liabilities | Q3 2026 · Dec 31, 2024 | $819.32M |
| Total Liabilities | Q3 2026 · Dec 31, 2025 | $1.49B |
| Total Liabilities | Q3 2026 · Mar 31, 2025 | $1.49B |
| Total Liabilities | Q3 2026 · Dec 31, 2024 | $1.55B |
| Current Assets | Q3 2026 · Dec 31, 2025 | $2.18B |
| Current Assets | Q3 2026 · Mar 31, 2025 | $2.16B |
| Current Assets | Q3 2026 · Dec 31, 2024 | $2.22B |
| Total Assets | Q3 2026 · Dec 31, 2025 | $3.02B |
| Total Assets | Q3 2026 · Mar 31, 2025 | $2.99B |
| Total Assets | Q3 2026 · Dec 31, 2024 | $3.04B |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | $1.32 |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | $3.02 |
| Eps Diluted | Q3 2026 · Dec 31, 2024 | $2.37 |
| Eps Diluted | Q3 2026 · Dec 31, 2024 | $3.41 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | $1.33 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | $3.03 |
| Eps Basic | Q3 2026 · Dec 31, 2024 | $2.39 |
| Eps Basic | Q3 2026 · Dec 31, 2024 | $3.44 |
| Sga Expense | Q3 2026 · Dec 31, 2025 | $76.93M |
| Sga Expense | Q3 2026 · Dec 31, 2025 | $228.3M |
| Sga Expense | Q3 2026 · Dec 31, 2024 | $89.51M |
| Sga Expense | Q3 2026 · Dec 31, 2024 | $232.04M |
| Net Income | Q3 2026 · Dec 31, 2025 | $33.25M |
| Net Income | Q3 2026 · Dec 31, 2025 | $75.92M |
| Net Income | Q3 2026 · Dec 31, 2024 | $59.64M |
| Net Income | Q3 2026 · Dec 31, 2024 | $85.71M |
| Operating Income | Q3 2026 · Dec 31, 2025 | $81.95M |
| Operating Income | Q3 2026 · Dec 31, 2025 | $183.41M |
| Operating Income | Q3 2026 · Dec 31, 2024 | $104.08M |
| Operating Income | Q3 2026 · Dec 31, 2024 | $190.04M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2025 | $701.7M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2025 | $1.8B |
| Cost Of Revenue | Q3 2026 · Dec 31, 2024 | $743.61M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2024 | $1.81B |
| Revenue | Q3 2026 · Dec 31, 2025 | $853.16M |
| Revenue | Q3 2026 · Dec 31, 2025 | $2.2B |
| Revenue | Q3 2026 · Dec 31, 2024 | $927.98M |
| Revenue | Q3 2026 · Dec 31, 2024 | $2.23B |